Clinical Trial Update: Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and immunogenicity when the HPV vaccine is co-administered with other vaccines in healthy female subjects. Results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2009-10-08